The Cigna Group (CI) stock analysis

Healthcare · Healthcare Plans

From the 10-K filed 2026-02-26

What protects it: the moat

It secures earnings through a network of 1.7 million physicians and multiyear service agreements with major health insurers Centene and Prime Therapeutics.

Competitive advantage is maintained via scale and high provider retention. The company leverages proprietary Therapeutic Resource Centers at Accredo, where pharmacists specialize in specific complex conditions like rare diseases.

Contracts with major clients like Centene and the Department of War (TRICARE) involve complex integrations and multiyear terms that stabilize the volume of pharmacy and medical claims.

What growth costs

It spent $749 million on a 2025 strategic optimization program to improve efficiency and maintains significant inventory for its 35 specialty pharmacies.

Maintaining and growing earnings requires heavy investment in digital infrastructure and care management platforms like MD Live (virtual care) and EviCore.

Structural costs include the purchase of high-cost brand-name and generic pharmaceuticals, which are sourced either directly from manufacturers or through authorized wholesalers to stock fulfillment centers in states like Arizona and Indiana.

What could damage it

Earnings face impairment if the 10 largest retail pharmacy chains, which represent 47% of its network stores, terminate their nonexclusive and short-notice contracts.

The company is vulnerable to shifts in industry pricing benchmarks. If third-party metrics used to establish drug prices are no longer published or are legally mandated to change, it would disrupt the spread and fee structures in its pharmacy contracts.

Furthermore, legislative reforms targeting the pharmacy benefit manager (PBM) model could restrict its ability to collect or retain manufacturer rebates.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

More on CI

Other companies in Healthcare Plans